On June 22, 2026, India’s Food Safety and Standards Authority (FSSAI) issued a notice revising its food additive rules, with a direct impact on infant and young child food products. The change matters to ingredient exporters, infant food manufacturers, importers, and compliance teams because it sets a clear restriction that will take effect within a defined timeline and applies to both imported finished goods and locally compounded materials.

What the new restriction covers

According to the notice identified as F.No. FSSAI/ADM/2026/189, FSSAI announced on June 22, 2026 that, from September 1, 2026, High-purity Hyaluronic Acid may not be added to foods for infants and young children aged 0–36 months.

The restriction covers any specification of High-purity Hyaluronic Acid, including material with a molecular weight of at least 1,000 kDa and material with a molecular weight of 50 kDa or below.

The scope extends to imported finished products as well as locally compounded raw material blends intended for this age-group category.

The input information also indicates that Chinese HA exporters need to adjust product positioning for the Indian market and align technical document declarations accordingly.

Where the immediate pressure will appear

Export-facing ingredient business

From an industry perspective, companies exporting HA into India may be affected first at the product classification and customer communication stage. The key issue is not only whether the ingredient is sold, but whether its intended use involves infant and young child complementary foods for the 0–36 month segment.

Infant food formulation and manufacturing

Manufacturers serving the Indian market may face the most direct operational impact in formulation review, label alignment, and specification checks. Because the restriction applies across covered High-purity Hyaluronic Acid specifications, businesses in this category need to pay close attention to whether any current recipe, premix, or application file still references the restricted ingredient for the affected age range.

Import, sourcing, and compliance functions

Importers, sourcing teams, and regulatory affairs staff may see the impact in document handling and shipment readiness. What deserves closer attention is the consistency between product positioning, technical declarations, and the actual end-use category in India, especially where products or raw material blends are supplied across multiple age-group applications.

What companies should monitor now

Check age-group positioning in product files

Analysis shows that one practical priority is to review whether any product sold into India is positioned for 0–36 month complementary food use. This is likely to be the first point where the rule translates into business action.

Revisit technical declarations and supporting documents

The summary specifically points to technical document declarations. For companies already supplying HA-related materials or finished products into India, this makes documentation review a near-term task rather than a later compliance formality.

Separate policy wording from commercial use scenarios

Observably, the rule is tied to a defined product application and age band. Companies should therefore distinguish between the regulatory wording itself and how customers describe, market, or register products in actual trade practice.

Prepare for customer and supply chain communication

Businesses involved in cross-border supply should be ready to clarify scope, timing, and affected applications with customers and partners before September 1, 2026. This is especially relevant where contracts, forecasts, or in-transit planning still assume the previous product positioning.

How this should be read at this stage

Analysis shows that this is already more than a market rumor or an early consultation signal, because a notice has been issued and an effective date has been stated. At the same time, it is more appropriate to understand it as a targeted regulatory change within a specific application segment rather than a broad statement about all HA uses.

From an industry perspective, the larger significance lies in compliance boundaries for infant-category products in India. The immediate question is not market size or long-term substitution patterns, which are not confirmed in the input, but how quickly affected operators can align product scope, declarations, and customer-facing materials.

What the update means for the market

In practical terms, this development points to a clear compliance adjustment for businesses linked to infant and young child food applications in India. It is best understood as a concrete short-term regulatory change with longer-term signaling value for companies that rely on precise ingredient positioning across export markets.

A neutral reading today is that the rule creates an immediate need for review, especially for products touching the 0–36 month category, while broader commercial consequences still require continued observation.

Basis of this article

This article is based on the user-provided news title, event date, and event summary concerning FSSAI’s June 22, 2026 notice and its stated September 1, 2026 effective date.

For this type of industry update, relevant source categories typically include official notices, company disclosures, industry association updates, authoritative media reporting, and standards-related documents. A specific official source link was not provided in the input, so continued verification remains necessary.

Areas that still warrant follow-up include any further official clarification on implementation wording, downstream interpretation in trade practice, and how affected companies revise technical declarations for the Indian market.